Issuer: |
Morgan
Stanley |
Principal
Amount: |
AUD
650,000,000 |
Maturity
Date: |
September
30, 2021 |
Trade
Date: |
September
24, 2014 |
Original
Issue Date (Settlement): |
September
30, 2014 (T+4) |
Interest
Accrual Date: |
September
30, 2014 |
Issue
Price (Price to Public): |
100.00% |
Agentsˇ¦
Commission: |
0.40% |
All-in
Price: |
99.60% |
Net
Proceeds to Issuer: |
AUD
647,400,000 |
Interest
Rate: |
5.00%
per annum |
Interest
Payment Period: |
Semi-annual |
Interest
Payment Dates: |
Each
March 30 and September 30, commencing March 30, 2015 |
Day
Count Convention: |
Actual/Actual
(ICMA) |
Specified
Currency: |
Australian
Dollars (ˇ§AUDˇ¨) |
Minimum
Denomination: |
AUD
1,000 and integral multiples of AUD 1,000 in excess
thereof |
Business
Days: |
New
York and Sydney |
Benchmark: |
Semi/Quarterly
Asset Swap |
Re-Offer
Yield: |
5.00%
semi-annual |
Re-Offer
Spread to Benchmark: |
+
144 bps |
Re-Offer
Spread to ACGB: |
ACGB
5.75% due May 15, 2021 + 173.75 bps |
ISIN: |
XS1115524016 |
Common
Code: |
111552401 |
Form: |
Registered;
issued under the Classic Safekeeping Structure |
Issuer
Ratings: |
Baa2
(Moodyˇ¦s) / A- (Standard & Poorˇ¦s) / A (Fitch) / A (R&I) / A
(high) (DBRS) (Positive / Negative / Stable / Negative /
Stable) |
Minimum
Purchase; Selling Restrictions: |
In
addition to the selling restrictions beginning on page S-43 in the
accompanying prospectus supplement dated November 21, 2011, the following
selling and other restrictions also apply to the notes:
Australia
The subscription and purchase
price for offers made in, to or from Australia must be at least AUD
500,000 disregarding moneys lent by the offeror or its associates (or the
offer for the issue or sale of the notes must otherwise not require
disclosure to investors under Parts 6D.2 or 7.9 of the Corporations Act
2001 of Australia (ˇ§Corporations Actˇ¨)).
No prospectus or other
disclosure document (as defined in the Corporations Act) in relation to
the program or the notes has been lodged with, or registered by, the
Australian Securities and Investments Commission (ˇ§ASICˇ¨). Each agent has
represented and agreed, or will represent and agree, that it:
(a) has
not made or invited, and will not make or invite, an offer of the
|
notes
for issue or sale in Australia (including an offer or invitation which is
received by a person in Australia); and
(b) has
not distributed or published, and will not distribute or publish, the
prospectus, prospectus supplement, pricing supplement or other offering
material or advertisement relating to the notes in
Australia,
unless:
(i) the
aggregate consideration payable by each offeree is at least AUD 500,000
(or its equivalent in an alternate currency) (and in either case,
disregarding moneys lent by the offeror or its associates) or the offer or
invitation otherwise does not require disclosure to investors in
accordance with Parts 6D.2 or Part 7.9 of the Corporations
Act;
(ii) such action
complies with all applicable laws, regulations and
directives;
(iii) the
offer or invitation does not constitute an offer to a person who is a
ˇ§retail clientˇ¨ for the purposes of section 761G of the Corporations Act;
and
(iv) such
action does not require any document to be lodged with
ASIC.
European Economic
Area
None of this free writing
prospectus, the accompanying prospectus supplement or the accompanying
prospectus is a prospectus for the purposes of the European Unionˇ¦s
Directive 2003/71 (and any amendments thereto) as implemented in member
states of the European Economic Area (the ˇ§Prospectus Directiveˇ¨).
This free writing prospectus, the accompanying prospectus supplement and
the accompanying prospectus have been prepared on the basis that all
offers of the notes described herein and therein made to persons in the
European Economic Area will be made pursuant to an exemption under the
Prospectus Directive from the requirement to produce a prospectus in
connection with offers of the notes.
United
Kingdom
The communication of this free
writing prospectus, the accompanying prospectus supplement or the
accompanying prospectus and any other documents or materials relating to
the issue of the notes is not being made, and such documents and/or
materials have not been approved, by an authorised person for the purposes
of section 21 of the Financial Services and Markets Act 2000. Accordingly,
such documents and/or materials are not being distributed to, and must not
be passed on to, the general public in the United Kingdom. The
communication of such documents and/or materials as a financial promotion
is only being made to those persons in the United Kingdom falling within
the definition of investment professionals (as defined in Article 19(5) of
the Financial Services and Markets Act 2000 (Financial Promotion) Order
2005 (the ˇ§Financial Promotion Orderˇ¨)) or within Article 49(2)(A) to (D)
of the Financial Promotion Order, or to any other persons to whom it may
otherwise lawfully be made under the Financial Promotion Order (all such
persons together being referred to as ˇ§relevant personsˇ¨). In the
United Kingdom the notes are only available to, and any investment or
investment activity to which this free writing prospectus, the
accompanying prospectus supplement or the accompanying prospectus relates
will be engaged in only with, relevant persons. Any person in the
United Kingdom that is not a relevant person should not act or rely on
this free writing prospectus, the accompanying prospectus supplement or
the accompanying prospectus or any of its or their
contents. | |
Agents: |
Morgan
Stanley & Co. International plc (ˇ§MSIPˇ¨), Australia and New Zealand
Banking Group Limited, National Australia Bank Limited and such other
agents as shall be named in the above-referenced Pricing
Supplement. MSIP is not a U.S. registered broker-dealer and,
therefore, to the extent that it intends to effect any sales of the notes
in the United States, it will do so through Morgan Stanley & Co. LLC
(ˇ§MS&Co.ˇ¨). MS&Co. is our wholly-owned subsidiary.
MS&Co. will therefore conduct this offering in compliance with the
requirements of Rule 5121 of the Financial Industry Regulatory Authority,
Inc., which is commonly referred to as FINRA, regarding a FINRA member
firmˇ¦s distribution of the securities of an affiliate and related
conflicts of interest. MS&Co. or any of our other
affiliates may not make sales in this offering to any discretionary
account without the prior written approval of the
customer. Australia and New Zealand Banking
Group |
Limited and National Australia Bank Limited are not U.S. registered broker-dealers and, therefore, to the extent that they intend to effect any sales of the notes in the United States, they will do so through one or more U.S. registered broker-dealers as permitted by FINRA regulations. |